Reed L. Benson's most recent trade in Co-Diagnostics Inc was a trade of 4,584 Restricted Stock Units done . Disclosure was reported to the exchange on May 24, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Co-Diagnostics Inc | Reed L. Benson | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2021 | 4,584 | 22,916 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Reed L. Benson | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 4,584 | 4,584 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Reed L. Benson | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.90 per share. | 24 May 2021 | 1,414 | 3,170 (0%) | 0% | 7.9 | 11,170 | Common Stock |
| Co-Diagnostics Inc | Reed L. Benson | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.63 per share. | 19 May 2021 | 97,413 | 108,334 (0%) | 0% | 2.6 | 256,196 | Common Stock |
| Co-Diagnostics Inc | Reed L. Benson | General Counsel | Sale of securities on an exchange or to another person at price $ 8.52 per share. | 19 May 2021 | 97,413 | 1 (0%) | 0% | 8.5 | 830,387 | Common Stock |
| Co-Diagnostics Inc | Reed L. Benson | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2021 | 97,413 | 0 | - | - | Stock Option (Right to Buy) | |
| Co-Diagnostics Inc | Reed L. Benson | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2021 | 10,920 | 0 | - | - | Stock Option (Right to Buy) | |
| Co-Diagnostics Inc | Reed L. Benson | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.63 per share. | 19 May 2021 | 10,920 | 10,921 (0%) | 0% | 2.6 | 28,720 | Common Stock |
| Co-Diagnostics Inc | Reed L. Benson | General Counsel | Sale of securities on an exchange or to another person at price $ 8.54 per share. | 19 May 2021 | 10,920 | 97,414 (0%) | 0% | 8.5 | 93,232 | Common Stock |
| Co-Diagnostics Inc | Reed L. Benson | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. | 19 May 2021 | 1 | 1 (0%) | 0% | 1 | 1 | Common Stock |
| Co-Diagnostics Inc | Reed L. Benson | General Counsel | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 19 May 2021 | 1 | 0 (0%) | 0% | 9 | 9 | Common Stock |
| Co-Diagnostics Inc | Reed L. Benson | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2021 | 1 | 13,891 | - | - | Stock Option (Right to Buy) |